This highlights the potential of ORMDL3 as a therapeutic target to offer more effective ways to manage IBD, potentially leading to improved patient outcomes and moving closer to the goal of achieving long-term remission or even a cure. Here, ORMDL3 is linked to inflammatory bowel disease.